Trending AI Posts & Hot Research Catchup - Page 178
Why BWET Soared 3,600% on the Hormuz Shipping Shock—and Why the Trade Is So Fragile
19 sources0BWET was up roughly 3,600% year to date through September 11, 2026 because it holds tanker freight futures that surged as Hormuz traffic collapsed and VLCC rates hit records—not because it simply tracks oil.
Fire Emblem: Fortune’s Weave Trailer: Release Date, Heroes and Blaze Arts Explained
19 sources0Fire Emblem: Fortune’s Weave is scheduled to launch exclusively for Nintendo Switch 2 on September 17, 2026.
How the Iran War Is Squeezing Gulf Economies—and Testing U.S. Security Ties
20 sources0The conflict’s core economic damage is the disruption of the Strait of Hormuz: higher oil prices help some producers, but cannot offset revenue lost when oil and LNG cannot move.
Iran War Puts Gulf States’ Nearly $4 Trillion US Investment Pledges at Risk
15 sources0The war is making nearly $4 trillion in Saudi, Qatari and UAE commitments to US investment and economic exchange less bankable: energy export disruptions, defence spending and weaker growth compete directly...
GSK’s Jideytro Reports 94% Response Rate in First-Line ROS1-Positive NSCLC Trial
16 sources0In 94 evaluable ROS1 TKI–naïve patients with advanced ROS1 positive NSCLC, Jideytro (zidesamtinib) produced a 94% objective response rate and 90% 12 month progression free survival.
France Reworks Under-15 Social Media Ban After Court Ruling as Macron Pushes EU-Wide Rule
27 sources0France’s blanket ban on social media for under 15s was struck down in August 2026 as a disproportionate restriction on freedom of expression and communication.
What did GSK report at the 2026 World Conference on Lung Cancer in Seoul about Jideytro (zidesamtinib), its ROS1 inhibitor, in the phase 1/2
14 sources0GSK reported that Jideytro (zidesamtinib) produced a 94% objective response rate in the evaluable, ROS1 TKI–naïve ARROS 1 cohort, with durable systemic and intracranial activity and comparatively few treatme...
Meta Smart Glasses Privacy Backlash: Why the Recording Light Isn’t Ending the Debate
30 sources0Meta’s recording LED is meant to signal photos and video, but reporting says camera based AI requests can use the glasses’ camera without lighting it.
Jideytro in First-Line ROS1-Positive NSCLC: GSK Reports 94% Response Rate in ARROS-1
13 sources0In ARROS 1, zidesamtinib (Jideytro) produced a 94% objective response rate (88 of 94 patients) in TKI naïve advanced ROS1 positive NSCLC, with 90% progression free at 12 months.
France Reworks Its Under-15 Social Media Ban After Court Rejection
24 sources0France has resubmitted under 15 social media restrictions to the European Commission after its Constitutional Council struck down the original blanket ban in August 2026 as a disproportionate limit on freedo...
Why Meta’s AI Smart Glasses Are Triggering a Privacy Backlash
33 sources0Meta says its capture LED is for photos and videos saved to a gallery, while critics argue that camera based AI analysis without that visible signal leaves bystanders unable to tell when they are being obser...
UCSF Brain Implant Decodes Speech and Gestures at the Same Time
18 sources0In a study of three people with vocal tract and limb paralysis, UCSF researchers used one 253 electrode cortical implant to decode intended speech and upper body gestures simultaneously, driving a personaliz...